Home > Products > CD20 & CD28 > Recombinant Anti-CD20 x Anti-CD28 Bispecific Antibody (Tandem Diabody)

Recombinant Anti-CD20 x Anti-CD28 Bispecific Antibody (Tandem Diabody)  (CAT#: T-BSDB-050)

Recombinant Anti-CD20 x Anti-CD28 Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can retarget T cells to tumor cells. It is designed for the research of Lymphoma therapy.
Datasheet INQUIRY

Specifications

Targets
CD20 & CD28
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Lymphoma

Targets

Target 1
CD20
Gene ID
UniProt ID
Alternative Names
MS4A1; membrane-spanning 4-domains, subfamily A, member 1; B1; S7; Bp35; CD20; CVID5; MS4A2; LEU-16; B-lymphocyte antigen CD20; CD20 antigen; CD20 receptor; leukocyte surface antigen Leu-16; B-lymphocyte cell-surface antigen B1
Target 2
CD28
Gene ID
UniProt ID
Alternative Names
CD28; CD28 molecule; Cluster of Differentiation 28; Tp44; T-cell-specific surface glycoprotein CD28; CD28 antigen
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD20 & CD28"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD20 x Anti-CD28 Bispecific Antibody (Tandem Diabody) (T-BSDB-050). Click the button below to contact us or submit your feedback about this product.